Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Athira Pharma, Inc. (ATHA) had Non-Operating Income/Expense of $0.88M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-28.74M |
|
-- |
|
-- |
|
$29.62M |
|
$-29.62M |
|
|
Non-Operating Income/Expense |
$0.88M |
$-28.74M |
|
$-28.74M |
|
$-28.74M |
|
$-28.74M |
|
$-28.74M |
|
$-28.74M |
|
$-29.62M |
|
$-29.43M |
|
38.52M |
|
38.52M |
|
$-0.75 |
|
$-0.75 |
|
| Balance Sheet Financials | |
$82.00M |
|
$2.69M |
|
$4.24M |
|
$86.25M |
|
$27.75M |
|
-- |
|
$0.91M |
|
$28.66M |
|
$57.58M |
|
$57.58M |
|
$57.58M |
|
38.67M |
|
| Cash Flow Statement Financials | |
$-71.16M |
|
$57.64M |
|
$0.16M |
|
$91.22M |
|
$77.86M |
|
$-13.36M |
|
$8.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.95 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-71.19M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-49.91% |
|
-49.91% |
|
-33.32% |
|
-49.91% |
|
$1.49 |
|
$-1.85 |
|
$-1.85 |
|